News

HSSA – Working Lunch Webinar

WORKING LUNCH WEBINAR

7 October 2021

We asked industry leaders and technical experts, including Medicines Australia and Pfizer Australia, to join us to discuss the importance of the National Health Security Resilience Assessment, and the opportunity for Australia’s industrial and research sectors to ensure their contributions count.

Speakers included:

• Dr Leigh Farrell, Head Health Security Systems Australia
• Ms Elizabeth de Somer, Chief Executive Medicines Australia
• Ms Anne Harris, Managing Director Pfizer Australia & New Zealand

You can watch the recording here:

Flow chemistry trial to validate local manufacture capability

A collaboration between Melbourne chemical company Boron Molecular and DMTC Limited is testing a new system capable of synthesising drugs at scale, quickly and continuously. (more…)

Celebrating success achieved through collaboration

DMTC Limited has released the digital version of its 2020 Annual Report, showcasing achievements across a broad portfolio of defence-relevant industrial innovation and technology development projects.

Read the report here.

Industry, researcher views sought to build national health security picture

The National Health Security Resilience Assessment 2020 (“NHSRA 2020”) is now live. Participation from the broadest range of respondents – encompassing government agencies, industrial and research organisations – is critical to developing a comprehensive picture of Australia’s sovereign preparedness posture. (more…)